Mitoxantrone and Standard Dose Cytosine Arabinoside Therapy in Refractory or Relapsed Acute Leukemia | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Mitoxantrone and Standard Dose Cytosine Arabinoside Therapy in Refractory or Relapsed Acute Leukemia

Acta Haematol (1994) 92 (1): 14–17.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Relapsed and Refractory Pediatric Acute Myeloid Leukemia: Current and Emerging Treatments

Jennifer Davila
Emily Slotkin
Thomas Renaud

Pediatric Drugs (2014) 16 (2): 151.

The Treatment of Acute Myeloid Leukemia in First Relapse: A Comprehensive Review of the Literature

Lance H. Leopold
Roel Willemze

Leukemia & Lymphoma (2002) 43 (9): 1715.

Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia

Guillermo Garcia-Manero
Deborah A. Thomas

Hematology/Oncology Clinics of North America (2001) 15 (1): 163.

Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine

Pia Raanani
Ofer Shpilberg
Shmuel Gillis
Abraham Avigdor
Izhar Hardan
Miriam Berkowicz
Orit Sofer
Izidore Lossos
Angela Chetrit
Dina Ben-Yehuda
Isaac Ben-Bassat

Leukemia Research (1999) 23 (8): 695.

Bolus and Continuous Infusion Mitoxantrone in Newly Diagnosed Adult Acute Lymphoblastic Leukemia: Results of Two Consecutive Phase II Clinical Studies: Original Articles

Yener Koc
Görgun Akpek
Emin Kansu
Ayse Kars
Gulten Tekuzman
Esmen Baltali
Nilüfer Guler
Ibrahim Barista
Ibrahim Gullü
Yavuz Ozisik
Dincer Firat

Cancer Investigation (1998) 16 (6): 355.